Global HIV Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 101
Published Date: 07 Jan 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
According to our (Global Info Research) latest study, the global HIV Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
This report is a detailed and comprehensive analysis for global HIV Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HIV Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global HIV Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global HIV Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global HIV Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HIV Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HIV Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie and F. Hoffmann-La Roche Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
HIV Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Market segment by Application
Hospitals
Clinics
Labs
Market segment by players, this report covers
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe HIV Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HIV Therapeutics, with revenue, gross margin and global market share of HIV Therapeutics from 2018 to 2023.
Chapter 3, the HIV Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and HIV Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of HIV Therapeutics.
Chapter 13, to describe HIV Therapeutics research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of HIV Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of HIV Therapeutics by Type
1.3.1 Overview: Global HIV Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global HIV Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.3.4 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.3.5 Entry and Fusion Inhibitors
1.3.6 Protease Inhibitors (PIs)
1.3.7 Integrase Inhibitors
1.3.8 Coreceptor Antagonists
1.4 Global HIV Therapeutics Market by Application
1.4.1 Overview: Global HIV Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Labs
1.5 Global HIV Therapeutics Market Size & Forecast
1.6 Global HIV Therapeutics Market Size and Forecast by Region
1.6.1 Global HIV Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global HIV Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America HIV Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe HIV Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific HIV Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America HIV Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa HIV Therapeutics Market Size and Prospect (2018-2029)
2.1 Boehringer Ingelheim International GmbH
2.1.1 Boehringer Ingelheim International GmbH Details
2.1.2 Boehringer Ingelheim International GmbH Major Business
2.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Product and Solutions
2.1.4 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
2.2 Merck & Co.
2.2.1 Merck & Co. Details
2.2.2 Merck & Co. Major Business
2.2.3 Merck & Co. HIV Therapeutics Product and Solutions
2.2.4 Merck & Co. HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co. Recent Developments and Future Plans
2.3 ViiV Healthcare
2.3.1 ViiV Healthcare Details
2.3.2 ViiV Healthcare Major Business
2.3.3 ViiV Healthcare HIV Therapeutics Product and Solutions
2.3.4 ViiV Healthcare HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ViiV Healthcare Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie HIV Therapeutics Product and Solutions
2.4.4 AbbVie HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product and Solutions
2.6.4 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb HIV Therapeutics Product and Solutions
2.7.4 Bristol-Myers Squibb HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences HIV Therapeutics Product and Solutions
2.8.4 Gilead Sciences HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Gilead Sciences Recent Developments and Future Plans
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson HIV Therapeutics Product and Solutions
2.9.4 Johnson & Johnson HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments and Future Plans
2.10 Cipla Limited
2.10.1 Cipla Limited Details
2.10.2 Cipla Limited Major Business
2.10.3 Cipla Limited HIV Therapeutics Product and Solutions
2.10.4 Cipla Limited HIV Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cipla Limited Recent Developments and Future Plans
3.1 Global HIV Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of HIV Therapeutics by Company Revenue
3.2.2 Top 3 HIV Therapeutics Players Market Share in 2022
3.2.3 Top 6 HIV Therapeutics Players Market Share in 2022
3.3 HIV Therapeutics Market: Overall Company Footprint Analysis
3.3.1 HIV Therapeutics Market: Region Footprint
3.3.2 HIV Therapeutics Market: Company Product Type Footprint
3.3.3 HIV Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global HIV Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global HIV Therapeutics Market Forecast by Type (2024-2029)
5.1 Global HIV Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global HIV Therapeutics Market Forecast by Application (2024-2029)
6.1 North America HIV Therapeutics Consumption Value by Type (2018-2029)
6.2 North America HIV Therapeutics Consumption Value by Application (2018-2029)
6.3 North America HIV Therapeutics Market Size by Country
6.3.1 North America HIV Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States HIV Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada HIV Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico HIV Therapeutics Market Size and Forecast (2018-2029)
7.1 Europe HIV Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe HIV Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe HIV Therapeutics Market Size by Country
7.3.1 Europe HIV Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany HIV Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France HIV Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom HIV Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia HIV Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy HIV Therapeutics Market Size and Forecast (2018-2029)
8.1 Asia-Pacific HIV Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific HIV Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific HIV Therapeutics Market Size by Region
8.3.1 Asia-Pacific HIV Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China HIV Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan HIV Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea HIV Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India HIV Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia HIV Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia HIV Therapeutics Market Size and Forecast (2018-2029)
9.1 South America HIV Therapeutics Consumption Value by Type (2018-2029)
9.2 South America HIV Therapeutics Consumption Value by Application (2018-2029)
9.3 South America HIV Therapeutics Market Size by Country
9.3.1 South America HIV Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil HIV Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina HIV Therapeutics Market Size and Forecast (2018-2029)
10.1 Middle East & Africa HIV Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa HIV Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa HIV Therapeutics Market Size by Country
10.3.1 Middle East & Africa HIV Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey HIV Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia HIV Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE HIV Therapeutics Market Size and Forecast (2018-2029)
11.1 HIV Therapeutics Market Drivers
11.2 HIV Therapeutics Market Restraints
11.3 HIV Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 HIV Therapeutics Industry Chain
12.2 HIV Therapeutics Upstream Analysis
12.3 HIV Therapeutics Midstream Analysis
12.4 HIV Therapeutics Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global HIV Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HIV Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global HIV Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global HIV Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Boehringer Ingelheim International GmbH Company Information, Head Office, and Major Competitors
Table 6. Boehringer Ingelheim International GmbH Major Business
Table 7. Boehringer Ingelheim International GmbH HIV Therapeutics Product and Solutions
Table 8. Boehringer Ingelheim International GmbH HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Boehringer Ingelheim International GmbH Recent Developments and Future Plans
Table 10. Merck & Co. Company Information, Head Office, and Major Competitors
Table 11. Merck & Co. Major Business
Table 12. Merck & Co. HIV Therapeutics Product and Solutions
Table 13. Merck & Co. HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck & Co. Recent Developments and Future Plans
Table 15. ViiV Healthcare Company Information, Head Office, and Major Competitors
Table 16. ViiV Healthcare Major Business
Table 17. ViiV Healthcare HIV Therapeutics Product and Solutions
Table 18. ViiV Healthcare HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ViiV Healthcare Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie HIV Therapeutics Product and Solutions
Table 23. AbbVie HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 26. F. Hoffmann-La Roche Ltd. Major Business
Table 27. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product and Solutions
Table 28. F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Major Business
Table 32. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 35. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 36. Bristol-Myers Squibb Major Business
Table 37. Bristol-Myers Squibb HIV Therapeutics Product and Solutions
Table 38. Bristol-Myers Squibb HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bristol-Myers Squibb Recent Developments and Future Plans
Table 40. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 41. Gilead Sciences Major Business
Table 42. Gilead Sciences HIV Therapeutics Product and Solutions
Table 43. Gilead Sciences HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Gilead Sciences Recent Developments and Future Plans
Table 45. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 46. Johnson & Johnson Major Business
Table 47. Johnson & Johnson HIV Therapeutics Product and Solutions
Table 48. Johnson & Johnson HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Johnson & Johnson Recent Developments and Future Plans
Table 50. Cipla Limited Company Information, Head Office, and Major Competitors
Table 51. Cipla Limited Major Business
Table 52. Cipla Limited HIV Therapeutics Product and Solutions
Table 53. Cipla Limited HIV Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cipla Limited Recent Developments and Future Plans
Table 55. Global HIV Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 56. Global HIV Therapeutics Revenue Share by Players (2018-2023)
Table 57. Breakdown of HIV Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in HIV Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key HIV Therapeutics Players
Table 60. HIV Therapeutics Market: Company Product Type Footprint
Table 61. HIV Therapeutics Market: Company Product Application Footprint
Table 62. HIV Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. HIV Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global HIV Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global HIV Therapeutics Consumption Value Share by Type (2018-2023)
Table 66. Global HIV Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 67. Global HIV Therapeutics Consumption Value by Application (2018-2023)
Table 68. Global HIV Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 69. North America HIV Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America HIV Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America HIV Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America HIV Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America HIV Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America HIV Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe HIV Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe HIV Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe HIV Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe HIV Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe HIV Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe HIV Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific HIV Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific HIV Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific HIV Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific HIV Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific HIV Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific HIV Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America HIV Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America HIV Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America HIV Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America HIV Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America HIV Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America HIV Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa HIV Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa HIV Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa HIV Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa HIV Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa HIV Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa HIV Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 99. HIV Therapeutics Raw Material
Table 100. Key Suppliers of HIV Therapeutics Raw Materials
List of Figures
Figure 1. HIV Therapeutics Picture
Figure 2. Global HIV Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HIV Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure 6. Entry and Fusion Inhibitors
Figure 7. Protease Inhibitors (PIs)
Figure 8. Integrase Inhibitors
Figure 9. Coreceptor Antagonists
Figure 10. Global HIV Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. HIV Therapeutics Consumption Value Market Share by Application in 2022
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Labs Picture
Figure 15. Global HIV Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global HIV Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market HIV Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global HIV Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 19. Global HIV Therapeutics Consumption Value Market Share by Region in 2022
Figure 20. North America HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. South America HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 25. Global HIV Therapeutics Revenue Share by Players in 2022
Figure 26. HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players HIV Therapeutics Market Share in 2022
Figure 28. Global Top 6 Players HIV Therapeutics Market Share in 2022
Figure 29. Global HIV Therapeutics Consumption Value Share by Type (2018-2023)
Figure 30. Global HIV Therapeutics Market Share Forecast by Type (2024-2029)
Figure 31. Global HIV Therapeutics Consumption Value Share by Application (2018-2023)
Figure 32. Global HIV Therapeutics Market Share Forecast by Application (2024-2029)
Figure 33. North America HIV Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 34. North America HIV Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 35. North America HIV Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 36. United States HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe HIV Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe HIV Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe HIV Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. France HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific HIV Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific HIV Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific HIV Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 50. China HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. India HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 56. South America HIV Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 57. South America HIV Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 58. South America HIV Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa HIV Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa HIV Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa HIV Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE HIV Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 67. HIV Therapeutics Market Drivers
Figure 68. HIV Therapeutics Market Restraints
Figure 69. HIV Therapeutics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of HIV Therapeutics in 2022
Figure 72. Manufacturing Process Analysis of HIV Therapeutics
Figure 73. HIV Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Boehringer Ingelheim International GmbH Merck & Co. ViiV Healthcare AbbVie F. Hoffmann-La Roche Ltd. Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Gilead Sciences Johnson & Johnson Cipla Limited
Related Reports
03 Jul 2021
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
